The treatment of Merkel cell carcinoma with immune checkpoint inhibitors: implications for patients with rheumatoid arthritis

OBJECTIVES: Merkel cell carcinoma (MCC) is a rare, highly aggressive neuroendocrine skin cancer, which typically affects elderly and immunocompromised and/or immunosuppressed patients. The checkpoint inhibitor avelumab, a mAb targeting the anti-programmed cell death ligand 1 (anti-PD-L1), has revolu...

Descripción completa

Detalles Bibliográficos
Autores principales: Klee, Gina, Kisch, Tobias, Kümpers, Christiane, Perner, Sven, Schinke, Susanne, Zillikens, Detlef, Langan, Ewan A, Terheyden, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Concise Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493100/
https://www.ncbi.nlm.nih.gov/pubmed/34622124
http://dx.doi.org/10.1093/rap/rkab037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493100/
https://www.ncbi.nlm.nih.gov/pubmed/34622124
http://dx.doi.org/10.1093/rap/rkab037

Ejemplares similares